Innate Pharma SA logo

Innate Pharma SA - Class A

NEW
XPAR:IPH (France)   Class A
€ 1.58 -0.030 (-1.86%) Sep 18
At Loss
Market Cap:
€ 176.49M ($ 202.72M)
Enterprise V:
€ 185.80M ($ 213.41M)
Volume:
280.97K
Avg Vol (2M):
491.86K
Trade In:
Volume:
280.97K
At Loss

Innate Pharma SA (XPAR:IPH) Dividend

Innate Pharma SA (XPAR:IPH) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -5.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XPAR:IPH Dividend

Does Innate Pharma SA (XPAR:IPH) pay a dividend?

Innate Pharma SA (XPAR:IPH) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Innate Pharma SA pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Innate Pharma SA has returned capital to shareholders via buybacks at a rate of -5.6% over the past 3 years.

What are dividend-paying alternatives to Innate Pharma SA?

For dividend-paying alternatives in Innate Pharma SA's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.